Cite
HARVARD Citation
Kotsakis, A. et al. (n.d.). Avelumab, an anti-PD-L1 monoclonal antibody, shows activity in various tumour types. Lancet oncology. 18 (5), pp. 556-557. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kotsakis, A. et al. (n.d.). Avelumab, an anti-PD-L1 monoclonal antibody, shows activity in various tumour types. Lancet oncology. 18 (5), pp. 556-557. [Online].